Mind Medicine Stock Working Capital
| MNMD Stock | USD 6.47 0.12 1.89% |
Mind Medicine fundamentals help investors to digest information that contributes to Mind Medicine's financial success or failures. It also enables traders to predict the movement of Mind Stock. The fundamental analysis module provides a way to measure Mind Medicine's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Mind Medicine stock.
| Last Reported | Projected for Next Year | ||
| Net Working Capital | 242.8 M | 142.5 M | |
| Change In Working Capital | -3.3 M | -3.2 M | |
| Working Capital | 171.4 K | 147.7 K |
Mind | Working Capital |
Mind Medicine Company Working Capital Analysis
Mind Medicine's Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .
More About Working Capital | All Equity Analysis
Working Capital | = | Current Assets | - | Current Liabilities |
Current Mind Medicine Working Capital | 242.77 M |
Most of Mind Medicine's fundamental indicators, such as Working Capital, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Mind Medicine is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Mind Working Capital Driver Correlations
Understanding the fundamental principles of building solid financial models for Mind Medicine is extremely important. It helps to project a fair market value of Mind Stock properly, considering its historical fundamentals such as Working Capital. Since Mind Medicine's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Mind Medicine's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Mind Medicine's interrelated accounts and indicators.
Click cells to compare fundamentals
Mind Working Capital Historical Pattern
Today, most investors in Mind Medicine Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Mind Medicine's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's working capital growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Mind Medicine working capital as a starting point in their analysis.
Mind Medicine Working Capital |
| Timeline |
Working Capital can be positive or negative, depending on how much of current debt the company is carrying on its balance sheet. In general terms, companies that have a lot of working capital will experience more growth in the near future since they can expand and improve their operations using existing resources. On the other hand, companies with small or negative working capital may lack the funds necessary for growth or future operation. Working Capital also shows if the company has sufficient liquid resources to satisfy short-term liabilities and operational expenses.
| Competition |
Mind Capital Surpluse
Capital Surpluse |
|
Based on the company's disclosures, Mind Medicine has a Working Capital of 242.77 M. This is 42.96% lower than that of the Biotechnology sector and 54.93% lower than that of the Health Care industry. The working capital for all United States stocks is 83.58% higher than that of the company.
Mind Working Capital Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Mind Medicine's direct or indirect competition against its Working Capital to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Mind Medicine could also be used in its relative valuation, which is a method of valuing Mind Medicine by comparing valuation metrics of similar companies.Mind Medicine is currently under evaluation in working capital category among its peers.
Mind Medicine ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Mind Medicine's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Mind Medicine's managers, analysts, and investors.Environmental | Governance | Social |
Mind Fundamentals
| Return On Equity | -0.68 | ||||
| Return On Asset | -0.3 | ||||
| Current Valuation | 226.7 M | ||||
| Shares Outstanding | 75.37 M | ||||
| Shares Owned By Insiders | 0.67 % | ||||
| Shares Owned By Institutions | 55.74 % | ||||
| Number Of Shares Shorted | 10.89 M | ||||
| Price To Book | 1.98 X | ||||
| EBITDA | (103.92 M) | ||||
| Net Income | (108.68 M) | ||||
| Cash And Equivalents | 105.74 M | ||||
| Cash Per Share | 3.71 X | ||||
| Total Debt | 21.85 M | ||||
| Current Ratio | 13.86 X | ||||
| Book Value Per Share | 3.21 X | ||||
| Cash Flow From Operations | (79.13 M) | ||||
| Short Ratio | 3.90 X | ||||
| Earnings Per Share | (1.54) X | ||||
| Target Price | 24.5 | ||||
| Number Of Employees | 74 | ||||
| Beta | 2.4 | ||||
| Market Capitalization | 478.59 M | ||||
| Total Asset | 302.15 M | ||||
| Retained Earnings | (398.88 M) | ||||
| Working Capital | 242.77 M | ||||
| Net Asset | 302.15 M |
About Mind Medicine Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Mind Medicine's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Mind Medicine using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Mind Medicine based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mind Medicine is a strong investment it is important to analyze Mind Medicine's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Mind Medicine's future performance. For an informed investment choice regarding Mind Stock, refer to the following important reports:Check out Mind Medicine Piotroski F Score and Mind Medicine Altman Z Score analysis. For information on how to trade Mind Stock refer to our How to Trade Mind Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mind Medicine. If investors know Mind will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mind Medicine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Mind Medicine is measured differently than its book value, which is the value of Mind that is recorded on the company's balance sheet. Investors also form their own opinion of Mind Medicine's value that differs from its market value or its book value, called intrinsic value, which is Mind Medicine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mind Medicine's market value can be influenced by many factors that don't directly affect Mind Medicine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mind Medicine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mind Medicine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mind Medicine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.